BDNF and Alzheimer disease: We have previously demonstrated that BSTSF can be used for the treatment of AD, potentially by ameliorating synaptic impairment by upregulating the expression levels of brain-derived neurotrophic factor (BDNF) and attenuating nerve inflammation (Hui et al., 2017; Xia et al., 2017).